Friday, June 20, 2008

FDA Update, 6/20/2008

New and Generic Drug Approvals

buprenorphine hydrochloride tablets, (Subutex) (treatment of opiate dependence) Roxane Laboratories, Inc., Tentative Approval
cetirizine hydrochloride syrup, (Zyrtec) (allergies) Apotex Corp., Approval
cetirizine hydrochloride syrup, Perrigo Israel Pharmaceuticals, Ltd.., Approval
Claritin (loratadine) (allergies) Capsules, Schering-Plough HealthCare Products, Approval hydromorphone hydrochloride injection, (pain relief) (Dilaudid) Hospira, Inc., Approval
metoprolol tartrate tablets, (Lopressor)Ohm Laboratories, Inc., Approval
trandolapril tablets, (Mavik)(hypertension)Glenmark Generics Inc., USA, Approval
Trivaris (triamcinolone acetonide) (occular inflammation)Injectable Suspension, Allergan, Inc., Approval

June 18, 2008

Cymbalta (duloxetine hydrochloride) Delayed-Release Capsules, Eli Lilly and Co., Approval
Requip XL (ropinirole) Extended-Release Tablets, (Parkinson's)GlaxoSmithKline, Approval
venlafaxine hydrochloride tablets, (Effexor) (depression)Caraco Pharmaceutical Laboratories, Ltd., Approval
venlafaxine hydrochloride tablets, Mylan Pharmaceuticals, Inc., Approval
venlafaxine hydrochloride tablets, Pliva Hrvatska, Approval
venlafaxine hydrochloride tablets, Sandoz, Inc., Approval
venlafaxine hydrochloride tablets, Zydus Pharmaceuticals USA, Inc., Approval

1 comment:

sisco said...

Great thoughts you got there, believe I may possibly try just some of it throughout my daily life.
Great thoughts you got there, believe I may possibly try just some of it throughout my daily life.